{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-016683","form_type":"8-K","ticker":"ASBP","cik":"0001847345","company_name":"Aspire Biopharma Holdings, Inc.","filed_at":"2026-04-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.116000+00:00","generated_at":"2026-05-15T06:10:16.113760+00:00","sec_items":["1.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Aspire Biopharma signs LOI to acquire Driver Controls Systems unit for $30M","bullets":["Entered non-binding LOI to acquire Driver Controls Systems business unit of Firefish Topco for $30M cash-free, debt-free.","Purchase price payable in cash at closing; no new equity raise anticipated.","Break-up fees of $3.5M applicable under certain circumstances; 30-day no-shop period.","Company plans to engage Lakewood & Company for management services post-closing.","Acquisition subject to definitive agreement; LOI non-binding except for exclusivity, confidentiality, and break-up fees."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-016683","json":"https://secwatch.observer/filing/0001493152-26-016683.json","markdown":"https://secwatch.observer/filing/0001493152-26-016683.md","text":"https://secwatch.observer/filing/0001493152-26-016683.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226016683/0001493152-26-016683-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226016683/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:10:16.113760+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9d3a0229ae2b3e10f6c710e397454a2468c3ca9c","claim":"Aspire Biopharma Holdings, Inc. entered into LOI with Firefish Topco, LLC valued at $30.0 million (effective 2026-04-15).","evidence_excerpt":"On April 15, 2026, Aspire Biopharma Holdings, Inc., a Delaware corporation (the “Company” or “Purchaser”) announced that it has entered into a non-binding letter of intent (the “LOI”) for the acquisition (as described below, the “Acquisition”) of 100% of the Driver Controls Systems business unit ( “DCS” ) of Firefish Topco, LLC","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226016683/0001493152-26-016683-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"Firefish Topco, LLC"},{"label":"Value","value":"$30.0 million"},{"label":"Effective","value":"2026-04-15"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}